Nuwellis (NASDAQ:NUWE) Trading 2.4% Higher – Time to Buy?

Nuwellis, Inc. (NASDAQ:NUWE) shares traded up 2.4% on Wednesday . The stock traded as high as $1.11 and last traded at $1.09. 76,039 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 898,355 shares. The stock had previously closed at $1.06.

Nuwellis Price Performance

The company has a market cap of $5.01 million, a price-to-earnings ratio of -0.01 and a beta of 0.32. The firm has a fifty day simple moving average of $1.49 and a 200 day simple moving average of $2.45.

Nuwellis (NASDAQ:NUWE) last released its earnings results on Monday, November 11th. The company reported $1.74 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.88) by $2.62. The firm had revenue of $2.37 million during the quarter, compared to analyst estimates of $2.40 million. Nuwellis had a negative net margin of 169.54% and a negative return on equity of 28,159.25%. During the same quarter in the previous year, the business earned ($63.29) EPS. Analysts expect that Nuwellis, Inc. will post -9.91 earnings per share for the current year.

Nuwellis Company Profile

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.